Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06082063 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Study acronym: Steno1
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Phase: Not applicable to Phase 3v2 Show 5 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2024 to Jul 1, 2024
    • Study sites: 0 to 2
    • Primary completion date: Feb 1, 2029 to Jul 1, 2029
    • Study completion date: Jan 1, 2030 to Jul 1, 2029
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Steno Diabetes Center Copenhagen
29 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
and 1 more disease
A prospective, randomised, open-labelled, multi-center study. The aim of the Steno 1 study is to test multifactorial intervention in individuals with type 1 diabetes at high risk of CVD with ambitious treatment targets. We will include 2000 participants. Follow-up is 5 years.
Trial Details
NCT Number NCT06082063
Lead Sponsor Steno Diabetes Center Copenhagen
Collaborators: Aarhus University Hospital, Steno Diabetes Center Nordjylland, Steno Diabetes Center Odense, Slagelse Hospital, Nykøbing Falster County Hospital, Zealand University Hospital, Hillerod Hospital, Denmark, Rigshospitalet, Denmark, Hvidovre University Hospital, Regionshospitalet Viborg, Skive, Randers Regional Hospital, Herning Hospital, Esbjerg Hospital - University Hospital of Southern Denmark, Regionshospitalet Silkeborg, Bispebjerg Hospital, Regionshospitalet Horsens
Conditions
(from sponsor)		 Cardiovascular Diseases, Heart Failure, Type 1 Diabetes, Kidney Failure
Related terms Cardiovascular Diseases, Diabetes Mellitus, Type 1, Heart Failure, Renal Insufficiency
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov